These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27581651)

  • 1. Identification of epigenetic factors regulating the mesenchyme to epithelium transition by RNA interference screening in breast cancer cells.
    Gregoire JM; Fleury L; Salazar-Cardozo C; Alby F; Masson V; Arimondo PB; Ausseil F
    BMC Cancer; 2016 Aug; 16(1):700. PubMed ID: 27581651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling.
    Jordan NV; Prat A; Abell AN; Zawistowski JS; Sciaky N; Karginova OA; Zhou B; Golitz BT; Perou CM; Johnson GL
    Mol Cell Biol; 2013 Aug; 33(15):3011-25. PubMed ID: 23716599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells.
    Punzi S; Balestrieri C; D'Alesio C; Bossi D; Dellino GI; Gatti E; Pruneri G; Criscitiello C; Lovati G; Meliksetyan M; Carugo A; Curigliano G; Natoli G; Pelicci PG; Lanfrancone L
    Breast Cancer Res; 2019 Nov; 21(1):123. PubMed ID: 31752957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
    Lee Y; Jung WH; Koo JS
    Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
    Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
    Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P; Gau Y; Sabnis G
    Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
    Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
    Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
    Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transmembrane prostate androgen-induced protein 1 (PMEPA1) promotes the migration and maintains mesenchymal-like phenotype of breast cancer cells].
    Zou Y; Zhang Y; Wang T; Wang S; Yang A; Jia L; Wang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):158-62. PubMed ID: 26927372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
    Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
    Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MED28 Regulates Epithelial-Mesenchymal Transition Through NFκB in Human Breast Cancer Cells.
    Huang CY; Hsieh NT; Li CI; Weng YT; Liu HS; Lee MF
    J Cell Physiol; 2017 Jun; 232(6):1337-1345. PubMed ID: 27662245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
    Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
    Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
    J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
    J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
    Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
    Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.